Latest Breaking News On - Mei pharma inc - Page 1 : vimarsana.com
MEI Pharma (MEIP) Reports Initial Data from Study of ME-344 in Combination with Bevacizumab
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MEI Pharma (MEIP) Board Aligns on Strategy to Advance Voruciclib and ME-344
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MEI Pharma (MEIP) Reports Update from Clinical Study of Voruciclib in Combination with Venetoclax
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MEI Pharma, Inc. (NASDAQ:MEIP – Get Free Report) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $6.02 and traded as low as $4.25. MEI Pharma shares last traded at $4.26, with a volume of 17,436 shares trading hands. Analysts Set New Price Targets A […]
Several analysts have recently updated their ratings and price targets for MEI Pharma (NASDAQ: MEIP): 2/14/2024 – MEI Pharma had its price target lowered by analysts at Stifel Nicolaus from $8.00 to $7.00. They now have a “hold” rating on the stock. 2/13/2024 – MEI Pharma was downgraded by analysts at StockNews.com from a “buy” […]